ES2060007T3 - 1-heteroaril-3-acil-2-oxindoles antiinflamatorios. - Google Patents

1-heteroaril-3-acil-2-oxindoles antiinflamatorios.

Info

Publication number
ES2060007T3
ES2060007T3 ES90300229T ES90300229T ES2060007T3 ES 2060007 T3 ES2060007 T3 ES 2060007T3 ES 90300229 T ES90300229 T ES 90300229T ES 90300229 T ES90300229 T ES 90300229T ES 2060007 T3 ES2060007 T3 ES 2060007T3
Authority
ES
Spain
Prior art keywords
oxindoles
alkyl
antiinflamatorios
heteroaril
acil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90300229T
Other languages
English (en)
Inventor
Anthony Marfat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2060007T3 publication Critical patent/ES2060007T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

CIERTOS 1-HETEROARILO-3-ACIL-2OXINDOLES EN DONDE EL SUSTITUYENTE DEL ACILO ES TIENOILO, FUROILO, BENZOILO O BENZOILO SUSTITUIDO, SON INHIBIDORES DE ENCIMAS CICLOXIGENASICAS Y LIPOXIGENASICAS Y RESULTAN UTILES COMO AGENTES ANTIINFLAMATORIOS EN MAMIFEROS.
ES90300229T 1989-01-10 1990-01-09 1-heteroaril-3-acil-2-oxindoles antiinflamatorios. Expired - Lifetime ES2060007T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000079 WO1990008145A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles

Publications (1)

Publication Number Publication Date
ES2060007T3 true ES2060007T3 (es) 1994-11-16

Family

ID=22214772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90300229T Expired - Lifetime ES2060007T3 (es) 1989-01-10 1990-01-09 1-heteroaril-3-acil-2-oxindoles antiinflamatorios.

Country Status (18)

Country Link
EP (1) EP0378358B1 (es)
JP (1) JPH0692400B2 (es)
KR (1) KR920006785B1 (es)
AT (1) ATE96793T1 (es)
AU (1) AU616336B2 (es)
CA (1) CA2007655C (es)
DE (1) DE69004272T2 (es)
DK (1) DK0378358T3 (es)
ES (1) ES2060007T3 (es)
FI (1) FI92827C (es)
HU (1) HU215112B (es)
IE (1) IE62143B1 (es)
IL (1) IL92962A (es)
NO (1) NO179103C (es)
NZ (1) NZ232039A (es)
PT (1) PT92800B (es)
WO (1) WO1990008145A1 (es)
ZA (1) ZA90139B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
CN108456205B (zh) * 2018-05-21 2021-06-04 深圳市众康动保科技有限公司 一种3,3二取代羟基吲哚化合物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
EP0276500B1 (en) * 1984-02-07 1991-05-15 Pfizer Inc. 2-oxindole intermediates
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
IN163263B (es) * 1984-02-07 1988-08-27 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
HU203238B (en) * 1984-08-24 1991-06-28 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
NO912694L (no) 1991-07-09
HUT62292A (en) 1993-04-28
NO912694D0 (no) 1991-07-09
CA2007655C (en) 1996-10-22
NO179103B (no) 1996-04-29
EP0378358B1 (en) 1993-11-03
AU4781690A (en) 1990-07-19
ZA90139B (en) 1991-08-28
EP0378358A1 (en) 1990-07-18
ATE96793T1 (de) 1993-11-15
NO179103C (no) 1996-08-07
KR900011762A (ko) 1990-08-02
DK0378358T3 (da) 1993-12-06
JPH02270868A (ja) 1990-11-05
JPH0692400B2 (ja) 1994-11-16
FI92827B (fi) 1994-09-30
HU215112B (hu) 1998-12-28
CA2007655A1 (en) 1991-07-12
AU616336B2 (en) 1991-10-24
DE69004272D1 (de) 1993-12-09
IE900075L (en) 1990-07-10
PT92800B (pt) 1995-12-29
FI92827C (fi) 1995-01-10
IL92962A (en) 1995-01-24
WO1990008145A1 (en) 1990-07-26
IE62143B1 (en) 1994-12-14
KR920006785B1 (ko) 1992-08-17
DE69004272T2 (de) 1994-02-24
FI913324A0 (fi) 1991-07-09
PT92800A (pt) 1990-07-31
NZ232039A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
FI970246A7 (fi) Dihydrobentsofuraanit
NZ516857A (en) Carbamate derivatives and agricultural/horticultural bactericides
DE3879264D1 (de) N-substituierte azole.
MX9305027A (es) 4- 2-(4-(2-piridiniloxi)fenil)etoxi] quinazolina yanalogos de la misma.
CA2169737A1 (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
DK1042319T3 (da) Dihydrobenzofuraner
AR002041A1 (es) Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.
DE59806655D1 (de) Pyranone, verfahren zu ihrer herstellung und verwendung
AR020950A1 (es) Compuestos de 3-(fenil sustituido)-5-tienil-1,2,4-triazolo con actividad contra la mosca blanca
ES2060007T3 (es) 1-heteroaril-3-acil-2-oxindoles antiinflamatorios.
DE3685823D1 (de) Sulfamoyl-harnstoff-derivate.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
ATE257833T1 (de) 2-arylalkylthio -imidazole, 2-arylalkenyl -thio - imidazole und 2-arylalkinyl -thio -imidazole als entzündungs -hemmstoffe und hemmstoffe der cytokin -freisetzung
MY104238A (en) Prodrugs of antiinflammatory 3-acyl-2-oxindole-1 -carboxamides.
DE69005833D1 (de) Entzündungshemmende 1-Heteroaryloxindole-3-Carboxamide.
KR910002818A (ko) 4,5,6,7-사치환된 벤즈옥사졸론
ATE263560T1 (de) Neue verwendung von citreamicinen
EP0365194A3 (en) Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
WO2001012642A3 (de) Nucleosidderivate und verfahren zu deren herstellung
DE69332232D1 (de) Immunsuppressive Enpyranosederivate
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
TW366344B (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 378358

Country of ref document: ES